Identification of erythroferrone as an erythroid regulator of iron metabolism

Kautz, Léon, Jung, Grace, Valore, Erika V, Rivella, Stefano, Nemeth, Elizabeta, Ganz, Tomas·2014·Nature Genetics

DOI 10.1038/ng.2996

Cited by (1,000)

Items 401–500 of 1,000

Live high, train low – influence on resting and post‐exercise hepcidin levels
Andrew David Govus, Peter Peeling, Chris R. Abbiss, Nathan G. Lawler, Dorine W. Swinkels, Coby M. Laarakkers, Kevin Thompson, Jeremiah J. Peiffer, Christopher J. Gore, Laura A. Garvican‐Lewis · 2016 · Scandinavian Journal of Medicine and Science in Sports
Effects of GlyT1 inhibition on erythropoiesis and iron homeostasis in rats
Michael Winter, Jürgen Funk, Annette Körner, Daniela Alberati, François Christen, Georg Schmitt, Bernd Altmann, A. Pospischil, Thomas Singer · 2016 · Experimental Hematology
The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease
Takeshi Nakanishi, Tomoko Kimura, Takahiro Kuragano · 2019 · Contributions to nephrology
Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS <i>in vivo</i>
Wallace, Daniel F., Subramaniam, V. Nathan · 2015 · International Immunology
An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms
Massimo Breccia, Maria Teresa Voso, Maria Antonietta Aloe Spiriti, Susanna Fenu, Luca Maurillo, Francesco Buccisano, Agostino Tafuri, Giuliana Alimena · 2015 · Annals of Hematology
Gastrointestinal iron excretion and reversal of iron excess in a mouse model of inherited iron excess
Courtney J. Mercadante, Milankumar Prajapati, Jignesh H. Parmar, Heather L. Conboy, Miriam E. Dash, Michael A. Pettiglio, Carolina Herrera, Julia T. Bu, Edward G. Stopa, Pedro Mendes et al. · 2018 · Haematologica
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
Marlijn P. A. Hoeks, Timothy Bagguley, Corine van Marrewijk, Alex G. Smith, David Bowen, Dominic J. Culligan, Seye Kolade, Argiris S. Symeonidis, Hege Gravdahl Garelius, Michail Spanoudakis et al. · 2020 · Leukemia
How Severe Anaemia Might Influence the Risk of Invasive Bacterial Infections in African Children
Kelvin M. Abuga, John M. Muriuki, Thomas Neil Williams, Sarah Helen Atkinson · 2020 · International Journal of Molecular Sciences
The Role of Iron in Benign and Malignant Hematopoiesis
Sayantani Sinha, Joana Pereira-Reis, Amaliris Guerra, Stefano Rivella, Delfim Duarte · 2020 · Antioxidants and Redox Signaling
Marginally reduced maternal hepatic and splenic ferroportin under severe nutritional iron deficiency in pregnancy maintains systemic iron supply
Rafał Mazgaj, Paweł Lipiński, Eunice Sindhuvi Edison, Aleksandra Bednarz, Robert Staroń, Olga Haberkiewicz, Małgorzata Lenartowicz, Ewa Smuda, Aneta Jończy, Rafał R. Starzyński · 2021 · American Journal of Hematology
Iron-mediated tissue damage in acquired ineffective erythropoiesis disease: It’s more a matter of burden or more of exposure to toxic iron form?
Federica Pilo, Daniela Cilloni, Matteo Giovanni Della Porta, Gian Luca Forni, Alberto Piperno, Valeria Santini, Emanuele Angelucci · 2022 · Leukemia Research
New strategies to target iron metabolism for the treatment of beta thalassemia
Paraskevi Rea Oikonomidou, Carla Casu, Stefano Rivella · 2016 · Annals of the New York Academy of Sciences
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS
Heather A. Leitch, Rena J. Buckstein, Nancy Yan Zhu, Thomas J. Nevill, Karen W L Yee, Brian F. Leber, Mary‐Margaret Keating, Ève St‐Hilaire, Rajat Kumar, Robert Delage et al. · 2018 · Leukemia Research
The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value
Antonella Roetto, Mariarosa Mezzanotte, Rosa Maria Pellegrino · 2018 · Pharmaceuticals
New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia
Liu, Jing, Liu, Wei, Liu, Yin, Miao, Yang, Guo, Yifan, Song, Haoyang, Wang, Fudi, Zhou, Hongyu, Ganz, Tomas, Yan, Bing et al. · 2019 · Haematologica
Elevated hepcidin serum level in response to inflammatory and iron signals in exercising athletes is independent of moderate supplementation with vitamin C and E
Víctor Díaz, Ana B. Peinado, Laura Barba‐Moreno, Sandro Altamura, Javier Butragueño, Marcela González‐Gross, Birgit Alteheld, Peter Stehle, Augusto G. Zapico, Martina Ulrike Muckenthaler et al. · 2015 · Physiological Reports
Two novel mutations (p.(Ser160Pro) and p.(Arg472Cys)) causing glucose-6-phosphate isomerase deficiency are associated with erythroid dysplasia and inappropriately suppressed hepcidin
Renata Mojzíková, Pavla Kořalková, Dušan Holub, Zuzana Saxova, Dagmar Pospı́šilová, Daniela Procházková, Petr Džubák, Monika Horváthová, Vladimír Divoký · 2017 · Blood Cells Molecules and Diseases
Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease
Yu Kurata, Tetsuhiro Tanaka, Masaomi Nangaku · 2020 · Current Opinion in Nephrology & Hypertension
Classic and emergent indicators for the assessment of human iron status
Mauricio Restrepo-Gallego, Luis E. Díaz, Patrícia Helen de Carvalho Rondó · 2020 · Critical Reviews in Food Science and Nutrition
Hepcidin and Erythroferrone Complement the Athlete Biological Passport in the Detection of Autologous Blood Transfusion
Andreas Breenfeldt Andersen, Jacob Bejder, Thomas Christian Bonne, HENRIK SØRENSEN, Helle Sørensen, GRACE JUNG, Tomas Ganz, Elizabeta Nemeth, Niels Henry Secher, Pär I. Johansson et al. · 2022 · Medicine & Science in Sports & Exercise
BMP5 contributes to hepcidin regulation and systemic iron homeostasis in mice
Xia Xiao, Yang Xu, Gillian A. Moschetta, Yang Yu, Allison L. Fisher, Víctor Manuel Alfaro-Magallanes, Shasta A. McMillen, Sydney Phillips, Chia‐Yu Wang, Jan L. Christian et al. · 2023 · Blood
Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation
H. Chen, Tenzin Choesang, Heng Li, Shuming Sun, P. Pham, W. Bao, M. Feola, M. Westerman, G. Li, Antonia Follenzi et al. · 2015 · Haematologica
Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia
Cornel S. G. Mirciov, Sarah J. Wilkins, Linda A. Dunn, Gregory Jon Anderson, David Michael Frazer · 2017 · PLoS ONE
Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia
Kazumichi Furuyama, Kiriko Kaneko · 2017 · International Journal of Hematology
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study
Belinda Spoto, Rahul K. Kakkar, Larry Lo, Matt Devalaraja, Patrizia Pizzini, Claudia Torino, Daniela Leonardis, Sebastiano Cutrupi, Giovanni Tripepi, Francesca Mallamaci et al. · 2019 · Journal of Clinical Medicine
Mouse genetic background impacts both on iron and non-iron metals parameters and on their relationships
Thibault Cavey, Martine Ropert, Marie de Tayrac, Edouard Bardou‐Jacquet, Marie‐Laure Island, Patricia Leroyer, Claude Bendavid, Pierre Brissot, Olivier Loréal · 2015 · BioMetals
Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders
Valeria Maria Pinto, Filippo Mazzi, Lucia De Franceschi · 2024 · Blood
Circulating factors are involved in hypoxia-induced hepcidin suppression
Giulia Ravasi, Sara Pelucchi, Federico Greni, Raffaella Mariani, Andrea Giuliano, Gianfranco Parati, Laura Silvestri, Alberto Piperno · 2014 · Blood Cells Molecules and Diseases
Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia
Miyuki Yokoro, Yosuke Nakayama, Sho‐ichi Yamagishi, Ryotaro Ando, Miki Sugiyama, Sakuya Ito, Junko Yano, Kensei Taguchi, Yusuke Kaida, Daisuke Saigusa et al. · 2017 · Journal of the American Society of Nephrology
Excessive Iron Availability Caused by Disorders of Interleukin-10 and Interleukin-22 Contributes to High Altitude Polycythemia
Yunsheng Liu, He Huang, Si-Min Zhou, Huai-jun Tian, Peng Li · 2018 · Frontiers in Physiology
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice
Irene Artuso, Mariateresa Pettinato, Antonella Nai, Alessia Pagani, Ugo Sardo, Benjamin Billoré, Maria Rosa Lidonnici, Cavan Bennett, Giacomo Mandelli, Sant‐Rayn Pasricha et al. · 2018 · Haematologica
Changes in Hepcidin Serum Levels Correlate with Clinical Improvement in Idiopathic Restless Legs Syndrome Patients
Hee‐Jin Im, Jee Hyun Kim, Chang‐Ho Yun, Dong Wook Kim, Jeeyoung Oh · 2020 · Journal of Clinical Medicine
Using the Zebrafish as a Genetic Model to Study Erythropoiesis
Zhang, Yuhan, Chen, Mengying, Chen, Caiyong · 2021 · International Journal of Molecular Sciences
Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice
Taku Nakai, Yuma Iwamura, Koichiro Kato, Ikuo Hirano, Yotaro Matsumoto, Yoshihisa Tomioka, Masayuki P. Yamamoto, Norio Suzuki · 2023 · Blood Advances
Effects of Pregnancy and Lactation on Iron Metabolism in Rats
Guofen Gao, Shang-Yuan Liu, Huijie Wang, Tian-Wei Zhang, Peng Yu, Xianglin Duan, Shu-E Zhao, Yan-Zhong Chang · 2015 · BioMed Research International
Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders
Caiyi Wang, Zheng Fang, Zesen Zhu, Jing Liu, Huiyong Chen · 2017 · Experimental Hematology
The BMP‐SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE‐A260S variant
Immacolata Andolfo, Barbara Eleni Rosato, Roberta Marra, Gianluca De Rosa, Francesco Manna, Antonella Gambale, Achille Iolascon, Roberta Russo · 2019 · American Journal of Hematology
Mechanism and regulation of iron absorption throughout the life cycle
Lili Qiu, David Michael Frazer, Mengxiao Hu, Rui Song, Xiaoxue Liu, Xiyu Qin, Jie Ma, Jun Zhou, Zidi Tan, Fazheng Ren et al. · 2025 · Journal of Advanced Research
Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia
Claire L. Shovlin · 2015 · Frontiers in Genetics
Utilisation des dérivés injectables du fer au cours de la maladie rénale chronique : intérêts, limites et conseils pour un bon usage
Jacques B. Rottembourg, Guy Rostoker · 2015 · Néphrologie & Thérapeutique
Saturated Fatty Acids Induce Post-transcriptional Regulation of HAMP mRNA via AU-rich Element-binding Protein, Human Antigen R (HuR)
Sizhao Lu, Justin L. Mott, Duygu Dee Harrison-Findik · 2015 · Journal of Biological Chemistry
Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial
Andreas Breenfeldt Andersen, Thomas Christian Bonne, Jacob Bejder, Grace Jung, Tomas Ganz, Elizabeta Nemeth, Niels Vidiendal Olsen, Jesús R. Huertas, Nikolai Baastrup Nordsborg · 2021 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Iron Mining for Erythropoiesis
Margherita Correnti, Elena Gammella, Gaetano Cairo, Stefania Recalcati · 2022 · International Journal of Molecular Sciences
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
Mark J. Koury, Rajiv Agarwal, Glenn Matthew Chertow, Kai‐Uwe Eckardt, Steven N. Fishbane, Tomas Ganz, Volker H. Haase, Mark R. Hanudel, Patrick S. Parfrey, Pablo E. Pérgola et al. · 2022 · American Journal of Hematology
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis
Shivani Handa, Yelena Z. Ginzburg, Ronald Hoffman, Marina Kremyanskaya · 2022 · Current Opinion in Hematology
Reduced cancer mortality at high altitude: The role of glucose, lipids, iron and physical activity
Markus Thiersch, Erik Richard Swenson, Thomas Haider, Max Gassmann · 2017 · Experimental Cell Research
Haemoglobin and the Inherited Disorders of Globin Synthesis
Swee Lay Thein, David C. Rees · 2015
Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia
Annelies J. van Vuren, Michele Freerk Eisenga, Stephanie van Straaten, Andreas Birkedal Glenthøj, Sandrine Gaillard, Stephan J. L. Bakker, Martin H. de Borst, Richard van Wijk, Eduard Johannes van Beers · 2020 · Blood Advances
Intravenous iron therapy and the cardiovascular system: risks and benefits
Lucia Del Vecchio, Robert Ekart, Charles Joseph Ferro, Jolanta Małyszko, Patrick Barry Mark, Alberto Ortíz, Pantelis A. Sarafidis, José Manuel Valdivielso, Francesca Mallamaci, for the ERA-EDTA European Renal and Cardiovascular Medicine Working (EURECA-m) Group · 2020 · Clinical Kidney Journal
Receptor-mediated mitophagy regulates EPO production and protects against renal anemia
Guangfeng Geng, Jinhua Liu, Zefeng Xu, Yandong Pei, Linbo Chen, Chenglong Mu, Ding Wang, Jie Gao, Yue Li, Jing Liang et al. · 2021 · eLife
Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia
Joseph D. Olivera, Vida Zhang, Elizabeta Nemeth, Tomas Ganz · 2023 · Blood Advances
Umbilical Cord Serum Ferritin Concentration is Inversely Associated with Umbilical Cord Hemoglobin in Neonates Born to Adolescents Carrying Singletons and Women Carrying Multiples
Katherine M. Delaney, Ronnie Guillet, Robert E. Fleming, Yuan Ru, Eva K. Pressman, Françoise Vermeylen, Elizabeta Nemeth, Kimberly O O'Brien · 2018 · Journal of Nutrition
Signaling pathways regulating hepcidin
Gautam Rishi, V. Nathan Subramaniam · 2019 · Vitamins and hormones
Treatment of Iron Deficiency Anemia in Adults
Robert T. Means · 2019 · Cambridge University Press eBooks
HDAC1 governs iron homeostasis independent of histone deacetylation in iron-overload murine models
Yin, Xiangju, Wu, Qian, Monga, Jitender, Xie, Enjun, Wang, Hao, Wang, Shufen, Zhang, Huizhen, Wang, Zhan-You, Zhou, Tianhua, Shi, Yujun et al. · 2018 · Antioxidants & Redox Signaling
Advances of Iron and Ferroptosis in Diabetic Kidney Disease
Jiayi Chu, Kewu Wang, Lulu Lu, Hui Zhao, Jibo Hu, Wenbo Xiao, Qian Wu · 2024 · Kidney International Reports
Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside
Yimin Dong, Meng Zheng, Weizhong Ding, Hanfeng Guan, Jun Xiao, Feng Li · 2025 · Redox Biology
Toxicity of Magnetic Nanoparticles in Medicine: Contributing Factors and Modern Assessment Methods
Julia Nowak‐Jary, Beata Machnicka · 2025 · International Journal of Molecular Sciences
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease
Violante Olivari, Simona Maria Di Modica, Maria Rosa Lidonnici, Mariam Aghajan, Celia Cordero-Sánchez, Emanuele Tanzi, Mariateresa Pettinato, Alessia Pagani, Francesca Tiboni, Laura Silvestri et al. · 2023 · Kidney International
Hepcidin as a potential biomarker for blood doping
Nicolas Leuenberger, Emanuele G. Bulla, Olivier Salamin, Raul Nicoli, Neil Robinson, Norbert Baume, Martial Saugy · 2016 · Drug Testing and Analysis
Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development
Antanas Planutis, Xue Li, Cecelia D. Trainor, Mohan Dangeti, Kevin Robert Gillinder, Mirosława Siatecka, Danitza Nébor, Luanne L. Peters, Andrew Charles Perkins, James J. Bieker · 2017 · Development
Hepcidin regulation in a mouse model of acute hypoxia
Giulia Ravasi, Sara Pelucchi, Gaia Buoli Comani, Federico Greni, Raffaella Mariani, Irene Pelloni, Silvia Bombelli, R Perego, Donatella Barisani, Alberto Piperno · 2018 · European Journal Of Haematology
Mutant KLF1 in Adult Anemic Nan Mice Leads to Profound Transcriptome Changes and Disordered Erythropoiesis
Danitza Nébor, Joel H. Graber, Steven L. Ciciotte, Raymond F. Robledo, Julien Papoin, Emily Hartman, Kevin Robert Gillinder, Andrew Charles Perkins, James J. Bieker, Lionel Blanc et al. · 2018 · Scientific Reports
GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1‐mediated BMP‐SMAD signalling suppression
Zheng Fang, Zesen Zhu, Haihang Zhang, Yuanliang Peng, Jin Liu, Hongyu Lu, Li Jiang, Long Liang, Shenghua Xia, Qiguang Wang et al. · 2019 · British Journal of Haematology
Erythroferrone as a sensitive biomarker to detect stimulation of erythropoiesis
Kelvin Ramirez Cuevas, Céline Schobinger, Emeric Gottardo, Sven Christian Voss, Tiia Kuuranne, Jean‐Daniel Tissot, Bernard Favrat, Nathan Townsend, Nicolas Leuenberger · 2019 · Drug Testing and Analysis
New diagnostic tools for delineating iron status
Yelena Z. Ginzburg · 2019 · Hematology
Influence of iron manipulation on hypoxic pulmonary vasoconstriction and pulmonary reactivity during ascent and acclimatization to 5050 m
Chris K. Willie, Alexander Patrician, Ryan L. Hoiland, Alexandra M. Williams, Christopher Gasho, Prajan Subedi, James D. Anholm, Aimee Louise Drane, Michael M. Tymko, Daniela Nowak‐Flück et al. · 2021 · The Journal of Physiology
Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia
Katherine M. Delaney, Ronnie Guillet, Eva K. Pressman, Tomas Ganz, Elizabeta Nemeth, Kimberly O O'Brien · 2021 · Journal of Nutrition
How I Diagnose Non-thalassemic Microcytic Anemias
Mariasole Bruno, Luigia De Falco, Achille Iolascon · 2015 · Seminars in Hematology
Hepcidin in chronic kidney disease anemia
Alice Santos‐Silva, Sandra Ribeiro, Flávio Reis, Luı́s Belo · 2019 · Vitamins and hormones
Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?
Claire L. Shovlin, Clare Gilson, Mark Busbridge, Dilip Patel, Chenyang Shi, Roberto E. Dina, F. Naziya Abdulla, Iman Awan · 2016 · The Laryngoscope
Prepregnancy Obesity Is Not Associated with Iron Utilization during the Third Trimester
Mary Dawn Koenig, Elizabeth Klikuszowian, Kimberly O O'Brien, Heather A. Pauls, Alana D. Steffen, Victoria A. deMartelly, Rungnapa Ruchob, Lauren Welke, Nefertiti OjiNjideka Hemphill, Bazil LaBomascus et al. · 2020 · Journal of Nutrition
Essential role of systemic iron mobilization and redistribution for adaptive thermogenesis through HIF2-α/hepcidin axis
Jin‐Seon Yook, Mikyoung You, Jiyoung Kim, Ashley Mulcahy Toney, Rong Fan, Bhanwar Lal Puniya, Tomáš Helikar, Sophie Vaulont, Jean‐Christophe Deschemin, Meshail Okla et al. · 2021 · Proceedings of the National Academy of Sciences
Activation of the Hepcidin-Ferroportin1 pathway in the brain and astrocytic–neuronal crosstalk to counteract iron dyshomeostasis during aging
Mariarosa Mezzanotte, Giorgia Ammirata, Marina Boido, Serena Stanga, Antonella Roetto · 2022 · Scientific Reports
The Zinc Finger of Prolyl Hydroxylase Domain Protein 2 Is Essential for Efficient Hydroxylation of Hypoxia-Inducible Factor α
Patrick R. Arsenault, Daisheng Song, Yu Jin Chung, Tejvir S. Khurana, Frank S. Lee · 2016 · Molecular and Cellular Biology
Hepcidin: an important iron metabolism regulator in chronic kidney disease
Sandra Azevedo Antunes, Maria Eugênia Fernandes Canziani · 2016 · Brazilian Journal of Nephrology
Cardiac Hepcidin Expression Associates with Injury Independent of Iron
G. Fenna van Breda, Lennart G. Bongartz, Wenqing Zhuang, Rachel P. L. van Swelm, Jeanne C. L. M. Pertijs, Branko G. Braam, Maarten Jan Cramer, Dorine W. Swinkels, Pieter A. Doevendans, Marianne Christina Verhaar et al. · 2016 · American Journal of Nephrology
Role of Activins in Hepcidin Regulation during Malaria
Natasha Spottiswoode, Andrew E. Armitage, Andrew Richard Williams, Alex J. Fyfe, Sumi Biswas, Susanne H. C. Hodgson, David Llewellyn, Prateek Choudhary, Simon J. Draper, Patrick Emmet Duffy et al. · 2017 · Infection and Immunity
Critical Issues in Diamond-Blackfan Anemia and Prospects for Novel Treatment
Hojun Li, Harvey F. Lodish, Colin A. Sieff · 2018 · Hematology/Oncology Clinics of North America
Analytical and biological assessment of circulating human erythroferrone
Sarah L. Appleby, Janice Chew‐Harris, Richard William Troughton, Mark Richards, Christopher J. Pemberton · 2020 · Clinical Biochemistry
An evaluation of roxadustat for the treatment of anemia associated with chronic kidney disease
Yu Kurata, Tetsuhiro Tanaka, Masaomi Nangaku · 2021 · Expert Opinion on Pharmacotherapy
Iron deficiency anaemia
2001 · Practice Nursing
Biology of Erythropoiesis, Erythroid Differentiation, and Maturation
Thalia Papayannopoulou, Anna Ritá Migliaccio · 2017 · Elsevier eBooks
Activin receptor ligand traps in chronic kidney disease
WOLFGANG E. B. JELKMANN · 2018 · Current Opinion in Nephrology & Hypertension
A Prolonged Bout of Running Increases Hepcidin and Decreases Dietary Iron Absorption in Trained Female and Male Runners
David E Barney, James Ippolito, Claire E. Berryman, Stephen R. Hennigar · 2022 · Journal of Nutrition
Renal control of life-threatening malarial anemia
Qian Wu, Euclides Nenga Manuel Sacomboio, Lara Valente de Souza, Rui Martins, Jamil Zola Kitoko, Sílvia Cardoso, Temitope Wilson Ademolue, Tiago Paixão, Jaakko I. Lehtimäki, Ana Leonor Figueiredo et al. · 2023 · Cell Reports
Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats
Jana Frýdlová, P. Přikryl, Jaroslav Truksa, Lucas L. Falke, Xin Du, Iuliia Gurieva, Martin Vokurka, Jan Krijt · 2016 · PLoS ONE
Hepcidin and Anemia in Surgical Critical Care: A Prospective Cohort Study*
Jill R. Cherry‐Bukowiec, Milo Engoren, Arek J Wiktor, Krishnan Raghavendran, Lena M. Napolitano · 2018 · Critical Care Medicine
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?
Timothy M. Bahr, Diane M. Ward, Xuan Jia, Robin Kjerstin Ohls, Kendell R. German, Robert D. Christensen · 2021 · Blood Cells Molecules and Diseases
Anemia of Chronic Disease
Anatole Besarab, Stefan Hemmerich · 2017 · Springer eBooks
Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients
Hanan Kamel M. Saad, Alawiyah Awang Abd Rahman, Azly Sumanty Ab Ghani, Wan Rohani Wan Taib, Imilia Ismail, Muhammad Farid Johan, Abdullah Saleh Al-wajeeh, Hamid Ali Nagi Al‐Jamal · 2022 · Biomedicines
Coordinatively Unsaturated Fe 3+ Based Activatable Probes for Enhanced MRI and Therapy of Tumors
Peisen Zhang, Yi Hou, Jianfeng Zeng, Yingying Li, Zihua Wang, Ran Zhu, Tiancong Ma, Mingyuan Gao · 2019 · Angewandte Chemie
Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis
Amaliris Guerra, Hamideh Parhiz, Stefano Rivella · 2023 · Haematologica
Iron age: novel targets for iron overload
Carla Casu, Stefano Rivella · 2014 · Hematology
Postoperative intravenous iron: a simple strategy to improve outcomes
Manuel Múñoz, Michael Auerbach · 2016 · The Lancet Haematology
Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model
Sarah Millot, Constance Delaby, Boualem Moulouel, Thibaud Lefèbvre, Nathalie Pilard, Nicolas Ducrot, Cécile Ged, Philippe Lettéron, Lucia De Franceschi, Jean Charles Deybach et al. · 2016 · Haematologica
In a Mouse Model of Sepsis, Hepcidin Ablation Ameliorates Anemia More Effectively than Iron and Erythropoietin Treatment
Eeman Khorramian, Eileen Fung, Kristine J. Chua, Victoria R. Gabayan, Tomas Ganz, Elizabeta Nemeth, Airie Kim · 2017 · Shock
A computational model to understand mouse iron physiology and disease
Jignesh H. Parmar, Pedro Mendes · 2019 · PLoS Computational Biology
Effects of anti–TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease
Alfredo José Lucendo, Óscar Roncero, María Teresa Serrano-Duenas, Daniel Hervías, Luis Miguel Alcázar, Miriam-Ruiz-Ponce, Cristina Verdejo, Emilio José Laserna Mendieta, Rufo Humberto Lorente, Ángel Arias · 2019 · Digestive and Liver Disease
Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model
Rachel Harrington-Kandt, Elena Stylianou, Lucy A. Eddowes, Pei Jin Lim, Lisa K Stockdale, Nawamin Pinpathomrat, Naomi C. Bull, Janet Pasricha, Marta Ulaszewska, Yulia Beglov et al. · 2018 · PLoS ONE